BWS Financial reiterated coverage on Hawkins with a new price target
$HWKN
Specialty Chemicals
Consumer Discretionary
BWS Financial reiterated coverage of Hawkins with a rating of Buy and set a new price target of $44.00 from $33.50 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/24/2025 | Mkt Perform | Raymond James | |
| 4/14/2025 | $160.00 | Neutral → Buy | BWS Financial |
| 4/1/2025 | $125.00 | Market Outperform | CJS Securities |
| 10/16/2024 | Buy → Neutral | BWS Financial | |
| 8/7/2023 | $62.00 | Neutral → Buy | BWS Financial |
| 2/3/2022 | $44.00 → $52.00 | Buy | BWS Financial |
8-K - HAWKINS INC (0000046250) (Filer)
8-K - HAWKINS INC (0000046250) (Filer)
10-Q - HAWKINS INC (0000046250) (Filer)
Raymond James initiated coverage of Hawkins with a rating of Mkt Perform
BWS Financial upgraded Hawkins from Neutral to Buy and set a new price target of $160.00
CJS Securities initiated coverage of Hawkins with a rating of Market Outperform and set a new price target of $125.00
ROSEVILLE, Minn., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, today announced that Patrick Hawkins, Chief Executive Officer, and Jeff Oldenkamp, Chief Financial Officer, will participate in Seaport Research Partners' 14th Annual Summer Investor Conference. The conference will be held virtually August 19 to August 20, 2025 and is hosted by Seaport Research Partners. It is expected to include over 500 institutional buy-side investors and feature one-on-one and small group meetings. Hawkins will participate on August 20, 2025. For more information about the conference or to schedule a meeting with Hawkins manage
ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) today announced results for the three months ended June 29, 2025, its first quarter of fiscal 2026. First Quarter Fiscal Year 2026 Highlights: Record quarterly results for revenue, gross profit, operating income, net income, diluted earnings per share ("EPS") and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("adjusted EBITDA"), a non-GAAP measure.Revenue growth of 15%, including Water Treatment segment growth of 28% over the same period of the prior year.Gross profit increase of 12% over the same period of the prior year.Diluted EPS of $1.40 per share, an increase of $0.02, or 1%. A
ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Hawkins, Inc. (NASDAQ:HWKN), at its meeting on July 30, 2025, increased its quarterly cash dividend by 6% to $0.19 per share, payable August 29, 2025, to shareholders of record at the close of business on August 15, 2025. Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities i
4 - HAWKINS INC (0000046250) (Issuer)
4 - HAWKINS INC (0000046250) (Issuer)
4 - HAWKINS INC (0000046250) (Issuer)
4 - HAWKINS INC (0000046250) (Issuer)
4 - HAWKINS INC (0000046250) (Issuer)
4 - HAWKINS INC (0000046250) (Issuer)
SC 13G/A - HAWKINS INC (0000046250) (Subject)
SC 13G/A - HAWKINS INC (0000046250) (Subject)
SC 13G/A - HAWKINS INC (0000046250) (Subject)
ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) today announced results for the three months ended June 29, 2025, its first quarter of fiscal 2026. First Quarter Fiscal Year 2026 Highlights: Record quarterly results for revenue, gross profit, operating income, net income, diluted earnings per share ("EPS") and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("adjusted EBITDA"), a non-GAAP measure.Revenue growth of 15%, including Water Treatment segment growth of 28% over the same period of the prior year.Gross profit increase of 12% over the same period of the prior year.Diluted EPS of $1.40 per share, an increase of $0.02, or 1%. A
ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Hawkins, Inc. (NASDAQ:HWKN), at its meeting on July 30, 2025, increased its quarterly cash dividend by 6% to $0.19 per share, payable August 29, 2025, to shareholders of record at the close of business on August 15, 2025. Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities i
ROSEVILLE, Minn., July 16, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) announced today that it expects to release its financial results for its fiscal 2026 first quarter ended June 29, 2025 after the market closes on July 30, 2025 at approximately 4:10 p.m. Eastern Time. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities in 28 states and creates value for its customers through superb customer se
BALATON, Minn., Aug. 16, 2023 /PRNewswire/ -- The trū® Shrimp Companies, Inc. ("trū Shrimp") announced today that trū Shrimp has appointed Hawkins, Inc. ("Hawkins") (NASDAQ:HWKN) as the exclusive distributor of its trū® Chitosan products into the United States' pharmaceutical and medical device industries. trū Chitosan is derived from the exoskeletons of trū Shrimp's production of consumer shrimp. Chitosan is a molecule refined from the shell of shrimp and is used for numerous pharmaceutical and medical applications. trū Shrimp is the only United States producer of chitosan that meets the strict medical specifications of the United States Pharmacopoeia – National Formulary (USP-NF) monograph
Minneapolis, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced that John S. McKeon has notified us of his retirement from our Board of Directors and its committees effective as of December 31, 2020. Mr. McKeon has been a member of the Board since 1984 and has served as Chair of the Board since 2005. “We will miss Jack on the Board and appreciate his many years of dedicated service to Hawkins,” said Patrick H. Hawkins, Chief Executive Officer and President. “Over the 36 years that Jack has served on the Board, we have seen Hawkins grow tremendously in both size and scope. With his support and guidance, we have built a solid company that is poised for cont